| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/27/2007 | US20070225349 Substituted 4-(Indazol-3-yl)phenols |
| 09/27/2007 | US20070225308 2-Amino Quinazoline Derivative |
| 09/27/2007 | US20070225287 Substituted Arylpyrazines |
| 09/27/2007 | US20070225221 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 09/27/2007 | US20070225215 Modulation of Cartilage Homeostasis By Active Domains of Cell Binding Extracellular Matrix Molecules |
| 09/27/2007 | US20070224268 Process for preparing oral calcium compositions |
| 09/27/2007 | US20070224263 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 09/27/2007 | DE60125416T2 Stabilisierte formulierungen von 6-hydroxy-3-(4-(2-(piperidin-1-yl)ethoxy)phenoxy)-2-(4-methoxyphenyl)benzo(b)thiophen und deren salze Stabilized formulations of 6-hydroxy-3- (4- (2- (piperidin-1-yl) ethoxy) phenoxy) -2- (4-methoxyphenyl) benzo (b) thiophene and their salts |
| 09/27/2007 | DE102006013594A1 Quervernetzte Gele von Hyaluronsäure und deren Verwendung Cross-linked gels of hyaluronic acid and their use |
| 09/27/2007 | CA2645583A1 Methods of inhibiting btk and syk protein kinases |
| 09/26/2007 | EP1837040A2 Drug delivery matrices to enhance wound healing |
| 09/26/2007 | EP1836209A1 Crystalline forms of6-[(5s,9r)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl]nicotinic acid as inhibitors of cd18 integrins, icams and/or the lfa-1:icam interaction for the treatment of inflammations and immune diseases |
| 09/26/2007 | EP1835967A1 Systems for providing a reference plane for mounting an acetabular cup |
| 09/26/2007 | EP1835923A2 Regimens for intra-articular viscosupplementation |
| 09/26/2007 | EP1490364B1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
| 09/26/2007 | EP1417055A4 Use of copper chelators to inhibit the inactivation of protein c |
| 09/26/2007 | EP1414825B1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/26/2007 | EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/26/2007 | EP1383750B1 Urea derivatives as integrin alpha 4 antagonists |
| 09/26/2007 | EP1339678B1 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 09/26/2007 | EP1303520B1 Therapeutic compounds and methods |
| 09/26/2007 | EP1228046B1 Phthalazinone derivatives as pde 4 inhibitors |
| 09/26/2007 | CN200951202Y External use magnetic traditional Chinese medicine plaster for treating cervical vertebrae ache disease |
| 09/26/2007 | CN101043895A Once a day formulation for phosphate binders |
| 09/26/2007 | CN101041065A Method for preparing Duyiwei compound injection |
| 09/26/2007 | CN101041039A Traditional Chinese medicine composition took orally for treating hyperosteogeny |
| 09/26/2007 | CN101041036A Medicine liquid for reducing pain for external application |
| 09/26/2007 | CN101041030A Novel Bikang pill |
| 09/26/2007 | CN101041012A Compound Chinese traditional medicine for creating bone joint ligament loosing and dislocation |
| 09/26/2007 | CN101040990A Chinese traditional medicine compound took orally for treating gout |
| 09/26/2007 | CN101040986A Chinese traditional medicine compound took orally for treating cervical spondylotic radiculopathy |
| 09/26/2007 | CN101040985A Chinese traditional medicine compound took orally for treating osteonecrosis |
| 09/26/2007 | CN101040981A Chinese traditional medicine compound took orally for treating cervical spondylotic radiculopathy |
| 09/26/2007 | CN101040980A Chinese traditional medicine compound for treating protrusion of lumbar intervertebral disc for external application |
| 09/26/2007 | CN101040979A Chinese traditional medicine compound took orally for treating protrusion of lumbar intervertebral disc |
| 09/26/2007 | CN101040978A Chinese traditional medicine compound took orally for treating cervical spondylosis |
| 09/26/2007 | CN101040955A Medical cream for treating diseases of bones and joints and its preparing process |
| 09/26/2007 | CN101040949A Medicine compound for creating rheumatism and rheumatoid arthritis and the preparing method and apllication |
| 09/26/2007 | CN101040930A Chinese traditional medicine for treating protrusion of lumbar intervertebral disc for external application |
| 09/26/2007 | CN101040927A Chinese traditional medicine compound took orally for treating ankylosing spondylitis |
| 09/26/2007 | CN101040926A Chinese traditional medicine compound took orally for treating cervical spondylosis |
| 09/26/2007 | CN101040925A Traditional Chinese medicine composition for curing hyperosteogeny for external application |
| 09/26/2007 | CN101040922A Chinese traditional medicine compound for treating gout |
| 09/26/2007 | CN101040916A Fuming and steaming medicine for treating arthropathy |
| 09/26/2007 | CN101040910A Medicine for treating ankylosing spondylitis |
| 09/26/2007 | CN101040908A Chinese traditional medicine compound took orally for treating ankylosing spondylitis |
| 09/26/2007 | CN101040889A Traditional Chinese medicinal prepns. for treating osteoporosis |
| 09/26/2007 | CN101040882A Medicine for treating heperosteogeny and its prepn. method |
| 09/26/2007 | CN101040876A Traditional Chinese medicine composition took orally for curing hyperosteogeny |
| 09/26/2007 | CN101040874A Compound medicine took orally for treating osteoporosis |
| 09/26/2007 | CN101040862A Application of gastrodin in the medicine for treating rheumatoid arthritis |
| 09/26/2007 | CN101040850A Colchicine sustained-release pellets and the preparing method |
| 09/26/2007 | CN100339477C Methods and devices for tissure repair |
| 09/26/2007 | CN100339383C Medication towards target of bone, synthetic method and application |
| 09/26/2007 | CN100339376C Nitrogen-containing aromatic ring derivatives |
| 09/26/2007 | CN100339374C Compounds and methods for modulation of estrogen receptors |
| 09/26/2007 | CN100339102C Medicinal plaster for treating sinew and bone tissue injury pain, bone fracture, dislocation |
| 09/26/2007 | CN100339080C Antiviral compounds |
| 09/25/2007 | US7273875 Blocking tumor necrosis factor; antiinflammatory agents; respiratory system disorders; bronchodilator |
| 09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
| 09/25/2007 | US7273752 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 09/25/2007 | US7273744 Heparanase-like polypeptides |
| 09/25/2007 | US7273712 Methods and compositions for detecting compounds that modulate inflammatory responses |
| 09/25/2007 | US7273612 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 09/25/2007 | US7273609 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L |
| 09/25/2007 | CA2547947C Azole derivatives as active superoxide radical inhibitors |
| 09/25/2007 | CA2511753C Phospholipid derivatives |
| 09/25/2007 | CA2294607C Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases |
| 09/25/2007 | CA2294278C Chalcones having antiproliferative activity |
| 09/20/2007 | WO2007106525A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 09/20/2007 | WO2007105753A1 Triazole derivative or salt thereof |
| 09/20/2007 | WO2007105637A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | WO2007104719A1 Diphenylurea derivatives and their use as chloride channel blockers or bkca channel modulators |
| 09/20/2007 | WO2007104242A1 Compounds capable of inhibiting zinc ion metalloproteinases |
| 09/20/2007 | WO2007063311A3 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 09/20/2007 | WO2007063308A3 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 09/20/2007 | WO2006017384A3 Indazoles useful in treating cardiovascular diseases |
| 09/20/2007 | US20070219255 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 09/20/2007 | US20070219234 Thienopyridine Derivatives |
| 09/20/2007 | US20070219233 Substituted Indoles and Their Use as Integrin Antagonists |
| 09/20/2007 | US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both |
| 09/20/2007 | US20070219169 Pharmaceutical compositions comprising trimegestone |
| 09/20/2007 | US20070219128 Medical and health-care uses of pufferfish type I collagen extract and processes for producing said extract |
| 09/20/2007 | US20070219118 Therapeutic methods for nucleic acid delivery vehicles |
| 09/20/2007 | US20070218041 Topical composition having undifferentiated plant seed cells and method for using same |
| 09/20/2007 | DE4003844B4 Neue Cyclosporin enthaltende galenische Formulierungen New cyclosporin-containing pharmaceutical formulations |
| 09/20/2007 | CA2646336A1 Diphenylurea derivatives and their use as chloride channel blockers or bkca channel modulators |
| 09/20/2007 | CA2646154A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 09/20/2007 | CA2645712A1 Triazole derivative or salt thereof |
| 09/20/2007 | CA2644368A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/19/2007 | EP1834960A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/19/2007 | EP1833840A2 Potent lna oligonucleotides for the inhibition of hif-1a |
| 09/19/2007 | EP1833832A1 Napthyridine compounds as rock inhibitors |
| 09/19/2007 | EP1833505A1 Local treatment of bone defects with matrix releasing bmp or pth |
| 09/19/2007 | EP1833313A2 Compositions containing high omega-3 and low saturated fatty acid levels |
| 09/19/2007 | EP1499605B1 NF-KappaB INHIBITORS |
| 09/19/2007 | EP1496907B1 Tyrosine kinase inhibitors |
| 09/19/2007 | EP1480976B1 Thiazole derivatives as npy receptor antagonists |
| 09/19/2007 | EP1439841B1 Androgen receptor modulators and methods of use thereof |
| 09/19/2007 | EP1255844B1 Humanized anti-ccr2 antibodies and methods of use therefor |